Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
GermanyA study to evaluate the efficacy and safety of obinutuzumab compared to prednisolone in adults with newly onset minimal change disease
GermanyA study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer
GermanyA study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis
GermanyA study to evaluate the safety and effectiveness of QEL-005 in patients with diffuse cutaneous systemic sclerosis and difficult to treat rheumatoid arthritis
GermanyA study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer
GermanyA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
GermanyA study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
GermanyA study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis
GermanyA study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B
GermanyA study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases
GermanyA study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
